Browse drugs

…), the mean SDI 1.4 (1.6) and the mean ACCI 1.5 (1.5). The mean prednisone dose was 3.2 (2.2) mg/day. During follow-up, 88 flares occurred…

…ast 2 years AND was maintained in the absence of treatment with glucocorticoids and immunosuppressives. Associations between the baseline chara…

…ological, and renal involvement) as well as treatment exposure (corticosteroids, immunomodulators, immunosuppressants, biologic therapy) was as…

…e treated by GCs, 48 by HCQ (90.6%), 25 (47.2%) by at least one immunosuppressive drugs. we found a median SLEDAI-2kequal to 2 (IQR 6). Indeed, active …

…5%) patients resulted positive for antiphospholipid antibodies. Lupus anticoagulant had the highest prevalence 22%, followed by anticardiolipin ant…

…diolipin IgG and IgM, anti-beta2glycoprotein I IgG and IgM, and lupus anticoagulant).Results 295 patients with SLE were screened between 2014 and 2…

…ity, 51% were of European ethnicity and 49% had active disease (SLEDAI-2K >4). Multiple overlapping protein associations between univaria…

…had higher MPO-DNA at baseline (p = 0.040). Within progressors, citH3-DNA was higher in those positive for rheumatoid factor at baseline …

… (p: 0.01), longer SLE history (p: 0.014), and higher values of SLEDAI-2K at the event and 10 years before (p: 0.0023 and p: 0.0003, resp…

… dyslipidemia, hematological manifestations, and greater use of methotrexate and azathioprine. Cluster 3 showed a higher frequency of anti-D…

…al CVR assessment tools are not applicable. Among eligible pts, statin prescribing rates remain low. The moderate agreement between di…

…l-established UK CVD risk score); Assess current prescribing of statins for primary prevention in those with abnormal CT-CAD and elevat…